1. Market Research
  2. > Therametrics holding AG (TMX) - Financial and Strategic SWOT Analysis Review

Therametrics holding AG (TMX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

THERAMetrics holding AG (THERAMetrics), formerly mondoBIOTECH Holding AG, is a contract research and development organization (CRO). It discovers drugs for the treatment of rare diseases. It offers contract research and development services to various biopharmaceutical companies. The company develops medicinal product candidates by redirecting existing drugs through its proprietary Search and Match methodology for the treatment of orphan diseases; and validating its medicinal product candidates. THERAMetrics has strategic partnerships and licensing agreements for the development of ready-for-license medicinal product candidates. It has licensing collaborations with companies such as 23andMe, Inc., Biogen Idec, InterMune and Lung Rx. The company operates along with its subsidiaries, namely, THERAMetrics Discovery AG; THERAMetrics laboratories AG; www.mondobiotech.com, Inc.; and Pierrel Research International AG and its subsidiaries; in Switzerland, Liechtenstein, Italy, Germany, the US, Russia, the UK, Bulgaria, Serbia, Romania and Poland. THERAMetrics is headquartered in Stans, Switzerland.

Therametrics holding AG Key Recent Developments

Sep 02, 2015: THERAMetrics holding and Accelovance sign Master Agreement for collaboration in the Clinical Research area
Aug 18, 2015: THERAMetrics and Grünenthal Sign Collaboration Agreement on the use of the DRR2.0 System Technology
Jul 14, 2015: European Patent Office grants patent for treatment of Idiopathic Pulmonary Fibrosis to THERAMetrics
May 14, 2015: THERAMetrics announces the results of its Annual General Meeting and the elections to the Board of Directors
Apr 13, 2015: THERAMetrics holding announces today its financial results for 2014

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Therametrics holding AG (TMX) - Financial and Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Therametrics holding AG - Key Facts 6
Therametrics holding AG - Key Employees 7
Therametrics holding AG - Key Employee Biographies 8
Therametrics holding AG - Major Products and Services 9
Therametrics holding AG - History 10
Therametrics holding AG - Company Statement 14
Therametrics holding AG - Locations And Subsidiaries 15
Head Office 15
Other Locations and Subsidiaries 15
Section 2 - Company Analysis 16
Therametrics holding AG - Business Description 16
Therametrics holding AG - Corporate Strategy 17
Therametrics holding AG - SWOT Analysis 18
SWOT Analysis - Overview 18
Therametrics holding AG - Strengths 18
Strength - Research and Development 18
Strength - Orphan Drug Designation 18
Strength - Proprietary Technologies 18
Therametrics holding AG - Weaknesses 19
Weakness - Decline in Financial Performance 19
Weakness - Decline in Revenue from Americas and Switzerland 19
Therametrics holding AG - Opportunities 20
Opportunity - Business Initiatives 20
Opportunity - Growing Aged Population 20
Opportunity - Marketing Initiatives 20
Therametrics holding AG - Threats 21
Threat - Competition and Technological Change 21
Threat - Uncertain RandD Outcomes 21
Threat - Government Regulations 21
Therametrics holding AG - Key Competitors 22
Section 3 - Company Financial Ratios 23
Financial Ratios - Capital Market Ratios 23
Financial Ratios - Annual Ratios 24
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Section 4 - Company's Lifesciences Financial Deals and Alliances 28
Therametrics holding AG, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 28
Therametrics holding AG, Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 29
Therametrics holding AG, Recent Deals Summary 30
Section 5 - Company's Recent Developments 31
Sep 02, 2015: THERAMetrics holding and Accelovance sign Master Agreement for collaboration in the Clinical Research area 31
Aug 18, 2015: THERAMetrics and Grünenthal Sign Collaboration Agreement on the use of the DRR2.0 System Technology 32
Jul 14, 2015: European Patent Office grants patent for treatment of Idiopathic Pulmonary Fibrosis to THERAMetrics 33
May 14, 2015: THERAMetrics announces the results of its Annual General Meeting and the elections to the Board of Directors 34
Apr 13, 2015: THERAMetrics holding announces today its financial results for 2014 35
Feb 18, 2015: THERAMetrics holding presents its DRR2.0 tool at Life Sciences Israel 2015 36
Section 6 - Appendix 37
Methodology 37
Ratio Definitions 37
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Therametrics holding AG, Key Facts 6
Therametrics holding AG, Key Employees 7
Therametrics holding AG, Key Employee Biographies 8
Therametrics holding AG, Major Products and Services 9
Therametrics holding AG, History 10
Therametrics holding AG, Subsidiaries 15
Therametrics holding AG, Key Competitors 22
Therametrics holding AG, Ratios based on current share price 23
Therametrics holding AG, Annual Ratios 24
Therametrics holding AG, Interim Ratios 26
Therametrics holding AG, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 28
Therametrics holding AG, Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 29
Therametrics holding AG, Recent Deals Summary 30
Currency Codes 37
Capital Market Ratios 37
Equity Ratios 38
Profitability Ratios 38
Cost Ratios 39
Liquidity Ratios 39
Leverage Ratios 40
Efficiency Ratios 40

List of Figures
Therametrics holding AG, Performance Chart (2010 - 2014) 25
Therametrics holding AG, Ratio Charts 27
Therametrics holding AG, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 28
Therametrics holding AG, Pharmaceuticals and Healthcare, Deals by Type, 2010 to YTD 2016 29

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.